Already before IFN-α, patients who later develop depression show significant differences in the expression of several pathways compared with those who do not; in addition, by TW4 they show specific longitudinal changes in similar and additional pathways, related to inflammation, neuroplasticity, and oxidative stress. Here, IFNA1 is linked to depressive symptom measurement.